When does pathway inhibition count as astrocyte targeting in multiple sclerosis?

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2026-11-09
DOI
https://doi.org/10.3389/fimmu.2026.2018483
Primary Topic
Multiple Sclerosis Research Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

When does pathway inhibition count as astrocyte targeting in multiple sclerosis?

Ming Luo, Zhufeng Chen
Frontiers in Immunology
Multiple Sclerosis Research Studies
article

When does pathway inhibition count as astrocyte targeting in multiple sclerosis?

Ming Luo, Zhufeng Chen
article en

Abstract

No abstract available for this paper.
Frontiers in ImmunologyVol. 17
Wenzhou Medical University (CN), Lishui Central Hospital (CN)
Multiple Sclerosis Research Studies
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
When does pathway inhibition count as astrocyte targeting in multiple sclerosis? — Ming Luo, Zhufeng Chen · Frontiers in Immunology (2026) | TGRS Research Map | TGRS